ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 628,57
-0,56%
Dow Jones
39 150,33
0,04%
DAX
18 163,52
-0,41%
Brent Oil
84,39
0,00%
Bitcoin
64 112,11
-0,21%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. AstraZeneca Plc (PK) (AZNCF)

  7. AstraZeneca Plc (PK) (AZNCF) Actualités

AZNCF

AstraZeneca (PK) (AZNCF)

AstraZeneca Plc (PK)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:AZNCF
DateHeureSourceTitreSymboleSociété
18/06/202412h38Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
06/03/202413h21Edgar (US Regulatory)Form CERT - Certification by an exchange approving securities for listingUSOTC:AZNCFAstraZeneca Plc (PK)
05/03/202422h40Edgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]USOTC:AZNCFAstraZeneca Plc (PK)
21/02/202414h32Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]USOTC:AZNCFAstraZeneca Plc (PK)
21/02/202414h13Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:AZNCFAstraZeneca Plc (PK)
20/02/202423h19Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansUSOTC:AZNCFAstraZeneca Plc (PK)
20/02/202422h34Edgar (US Regulatory)Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).USOTC:AZNCFAstraZeneca Plc (PK)
12/02/202416h13Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:AZNCFAstraZeneca Plc (PK)
12/12/202323h15Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyUSOTC:AZNCFAstraZeneca Plc (PK)
09/11/202323h07Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipUSOTC:AZNCFAstraZeneca Plc (PK)
01/11/202320h15AllPennyStocks.comBiotech Shares Soar After AstraZeneca Stake & Research CollaborationUSOTC:AZNCFAstraZeneca Plc (PK)
16/08/202322h09Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesUSOTC:AZNCFAstraZeneca Plc (PK)
28/06/202323h28Edgar (US Regulatory)Annual Report of Employee Stock Plans (11-k)USOTC:AZNCFAstraZeneca Plc (PK)
02/06/202318h13Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:AZNCFAstraZeneca Plc (PK)
13/03/202321h38Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)USOTC:AZNCFAstraZeneca Plc (PK)
02/03/202322h55Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)USOTC:AZNCFAstraZeneca Plc (PK)
01/03/202312h27Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)USOTC:AZNCFAstraZeneca Plc (PK)
24/01/202319h59Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:AZNCFAstraZeneca Plc (PK)
08/07/202222h58Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:AZNCFAstraZeneca Plc (PK)
10/06/202222h11Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)USOTC:AZNCFAstraZeneca Plc (PK)
22/02/202223h43Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:AZNCFAstraZeneca Plc (PK)
22/02/202223h19Edgar (US Regulatory)Notice of Iran-related Disclosure Filed Pursuant to Section 13(r)(3) of the Exchange Act (irannotice)USOTC:AZNCFAstraZeneca Plc (PK)
04/02/202215h08Edgar (US Regulatory)Schedule 13gUSOTC:AZNCFAstraZeneca Plc (PK)
30/07/202113h40Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)USOTC:AZNCFAstraZeneca Plc (PK)
13/04/202112h06Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:AZNCFAstraZeneca Plc (PK)
13/04/202112h02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:AZNCFAstraZeneca Plc (PK)
09/04/202123h05Edgar (US Regulatory)Amended Securities Registration (foreign Private Issuer) (f-4/a)USOTC:AZNCFAstraZeneca Plc (PK)
19/02/202123h03Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-4)USOTC:AZNCFAstraZeneca Plc (PK)
13/11/202022h08Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...USOTC:AZNCFAstraZeneca Plc (PK)
01/10/202017h06Edgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:AZNCFAstraZeneca Plc (PK)
 Showing the most relevant articles for your search:USOTC:AZNCF

Dernières Valeurs Consultées

BOV
C2EM34
Cemex Sab de Cv
TSXV
KLDC
Kirkland Lake Discoveries
BIT
UC3S9S
Unicredit Bank
TG
T5Z
Ternium
UNSW3
UBEXETH
Ubex
COIN
HOTTKNBTC
HotNow HOT Token
OKEX
UMAETH
NYSE
RLI
RLI
NASDAQ
FWONA
Liberty Media
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés